GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 126 filers reported holding GENOMIC HEALTH INC in Q1 2017. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,585,000 | +2.1% | 87,943 | +0.5% | 0.00% | 0.0% |
| Q3 2016 | $2,532,000 | +4.3% | 87,540 | -6.6% | 0.00% | 0.0% |
| Q2 2016 | $2,427,000 | +8.5% | 93,730 | +3.8% | 0.00% | 0.0% |
| Q1 2016 | $2,236,000 | -28.6% | 90,258 | +1.5% | 0.00% | -25.0% |
| Q4 2015 | $3,130,000 | +66.4% | 88,934 | +0.1% | 0.00% | +33.3% |
| Q3 2015 | $1,881,000 | -23.9% | 88,881 | -0.1% | 0.00% | 0.0% |
| Q2 2015 | $2,472,000 | +7.4% | 88,940 | +18.0% | 0.00% | 0.0% |
| Q1 2015 | $2,302,000 | -3.1% | 75,353 | +1.4% | 0.00% | 0.0% |
| Q4 2014 | $2,375,000 | +42.4% | 74,296 | +26.1% | 0.00% | +50.0% |
| Q3 2014 | $1,668,000 | +3.3% | 58,907 | +0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,614,000 | +31.8% | 58,895 | +26.6% | 0.00% | 0.0% |
| Q1 2014 | $1,225,000 | -9.7% | 46,519 | +0.4% | 0.00% | 0.0% |
| Q4 2013 | $1,356,000 | -6.0% | 46,319 | -1.8% | 0.00% | 0.0% |
| Q3 2013 | $1,443,000 | +3.2% | 47,183 | +7.0% | 0.00% | 0.0% |
| Q2 2013 | $1,398,000 | – | 44,087 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 11,744,010 | $756,432,000 | 6.19% |
| EMORY UNIVERSITY | 30,319 | $1,953,000 | 1.54% |
| Copper Rock Capital Partners, LLC | 292,596 | $18,630,000 | 1.46% |
| DE BURLO GROUP INC | 73,600 | $4,740,000 | 1.06% |
| Eversept Partners, LP | 23,866 | $1,537,209 | 0.83% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 165,310 | $10,648,000 | 0.83% |
| Aurora Investment Counsel | 20,916 | $1,347,000 | 0.73% |
| Texas Children's | 8,035 | $518,000 | 0.72% |
| Capital Impact Advisors, LLC | 24,665 | $1,570,000 | 0.67% |
| Granahan Investment Management | 130,650 | $8,415,000 | 0.60% |